
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 1, Issue 5 361-368, Copyright © 1992 by American Association for Cancer Research
ARTICLES |
CJ Calleman, LG Stern, E Bergmark and LG Costa
Department of Environmental Health, University of Washington, Seattle 98195.
Hemoglobin cysteine adduct levels formed by acrylamide (AA) and its epoxide metabolite glycidamide (GA) as previously determined (Bergmark et al., Toxicol. Appl. Pharmacol., 111: 352-363, 1991) in rats given single injections of AA were used to estimate tissue doses, D = integral of Cdt (area under the concentration curve in the blood compartment), of the two compounds. The data were adapted to linear or nonlinear kinetic models, where the latter model accounted for the Michaelis-Menten kinetics of the metabolic conversion of AA to GA. In the linear model, the first-order rates, k*, of elimination from all processes were estimated to be 0.50 and 0.48 h-1 for AA and GA, respectively. In the nonlinear model, the parametrical values Vmax = 19.1 h-1 and Km = 66 microM for the in vivo metabolic conversion of AA to GA, and k1 = 0.21 h-1 and k2 = 0.48 h-1 for the first-order rates of elimination from all other processes of AA and GA, respectively, were found to give the best fit to the exact dosimetric expressions [formula: see text] Using Equation B, it was estimated that the percentage of AA converted to GA approaches 58% when [AA]o, the initial concentration of AA, approaches zero. The implications for high-to-low-dose extrapolation of toxic effects of the derived mathematical relationships between administered dose and tissue dose are discussed.
This article has been cited by other articles:
![]() |
T. R. Fennell, S. C.J. Sumner, R. W. Snyder, J. Burgess, R. Spicer, W. E. Bridson, and M. A. Friedman Metabolism and Hemoglobin Adduct Formation of Acrylamide in Humans Toxicol. Sci., May 1, 2005; 85(1): 447 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. J. Sumner, C. C. Williams, R. W. Snyder, W. L. Krol, B. Asgharian, and T. R. Fennell Acrylamide: A Comparison of Metabolism and Hemoglobin Adducts in Rodents following Dermal, Intraperitoneal, Oral, or Inhalation Exposure Toxicol. Sci., October 1, 2003; 75(2): 260 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Fennell, R. W. Snyder, W. L. Krol, and S. C. J. Sumner Comparison of the Hemoglobin Adducts Formed by Administration of N-Methylolacrylamide and Acrylamide to Rats Toxicol. Sci., February 1, 2003; 71(2): 164 - 175. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |